Vimarsana
Biggest News Aggregation in the World

Page 9 - Coherence Tomography News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Coherence Tomography. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Coherence Tomography Today - Breaking & Trending Today

Wrexham based company HOYA holds free vision screenings - Vimarsana News

Wrexham based company HOYA holds free vision screenings

A Wrexham-based optical lens company is helping to bridge the vision care gap as they marked World Sight Day.

Global Ophthalmic Diagnostics Equipment Market to Surpass US$ 4,064.5 Million by 2030 - Vimarsana News

Global Ophthalmic Diagnostics Equipment Market to Surpass US$ 4,064.5 Million by 2030

/PRNewswire/ -- According to Coherent Market Insights, the global ophthalmic diagnostics equipment market is estimated to be valued at US$ 2,502.6 million in...

Global Ophthalmic Diagnostics Equipment Market to Surpass US$ 4,064.5 Million by 2030 - Vimarsana News

Global Ophthalmic Diagnostics Equipment Market to Surpass US$ 4,064.5 Million by 2030

/PRNewswire/ -- According to Coherent Market Insights, the global ophthalmic diagnostics equipment market is estimated to be valued at US$ 2,502.6 million in...

Global Clinical Trial Imaging Market to be Valued $1.97 Billion by 2030: Grand View Research, Inc. - Vimarsana News

Global Clinical Trial Imaging Market to be Valued $1.97 Billion by 2030: Grand View Research, Inc.

/PRNewswire/ -- The global clinical trial imaging market is projected to expand at a CAGR of 8.7% from 2022 to 2030, according to a new report by Grand View...

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism - Vimarsana News

TRANSFORM 1 enrollment completed: A crucial RCT ready to redefine the DCB Angioplasty Mechanism

Birmingham [England], September 14 (ANI/PRNewswire): Concept Medical announces the successful completion of the TRANSFORM 1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch Sirolimus Coated Balloon). The Randomized Controlled Trial (RCT) was conceptualized with the aim of understanding how the treatment indications and applications of Drug-Coated Balloon (DCB) in coronary artery disease (CAD) can be broadened. This prospective, randomized, multi-centre, RCT focusing on small vessels, de-novo coronary lesion treatment enrolled the culminating 114th patient on...